El daño miocárdico mínimo durante el intervencionismo coronario percutáneo no influye en el pronóstico a largo plazo-Reference-Cited by-同舟云学术

El daño miocárdico mínimo durante el intervencionismo coronario percutáneo no influye en el pronóstico a largo plazo

Published:2009-06 Issue:6 Volume:62 Page:625-632
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

Gómez-Hospital Joan A.,Cequier Ángel,Valero José,González-Costello José,Mañas Pilar,Iràculis Emili,Teruel-Gila Luis M.,Maristany Jaume,Pascual Marcos,Jara Francesc,Esplugas Enrique

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT);Harrington;J Am Coll Cardiol,1995

2. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention: IMPACT-II Investigators: Integrelin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II;Tardiff;J Am Coll Cardiol,1999

3. Significance of mild transient release os creatine kinase-MB fraction after percutaneous coronary interventions;Abdelmeguid;Circulation,1996

4. Prognostic implication of creatine kinase elevation following coronary artery interventions;Kong;JAMA,1997

5. Long-term clinical events following creatine kinase-myocardial band isoenzime elevation after successful coronary stenting;Saucedo;J Am Coll Cardiol,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospective studies;EuroIntervention;2020-03

2. Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients;Coronary Artery Disease;2020-03

3. Left ventricular support with Impella for high risk percutaneous coronary intervention. The demonstration of the hemodynamic benefit in daily practice;International Journal of Cardiology;2019-01

4. Valor pronóstico de la troponina I posintervencionismo coronario percutáneo electivo;Gaceta de M�xico;2018-05-04

5. Prevention of minor myocardial injury after elective percutaneous coronary intervention: comparison of ticagrelor versus clopidogrel;Acta Cardiologica;2018-01-22